Hideto Kameda

37PUBLICATIONS
69CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityPredictive and prognostic markersRheumatology and arthritisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Nov 04, 2026
Successful treatment of refractory myositis-associated interstitial lung disease with an interleukin-6 inhibitor: four-patient case series.

|Sep 30, 2026
Tocilizumab for refractory cerebral arteritis in a patient with systemic lupus erythematosus.

|Jun 26, 2026
Achievement of intermediate treatment targets for Still's disease under tocilizumab treatment: a post-hoc analysis of the phase III trial.

|May 12, 2026
Real-world effectiveness, safety and patient-reported outcomes of sarilumab in patients with rheumatoid arthritis: a 52-week, prospective, open-label, non-interventional, observational, nationwide, large-cohort study in Japan (PROFILE-J).

|Jan 29, 2026
Long-term safety and efficacy of tocilizumab in adult-onset Still's disease: open-label, long-term extension of the phase III trial.

Koji Suzuki, Hideto Kameda, Kei Ikeda

|Jan 28, 2026
Ultrasound evaluation of finger joint cartilage damage progression in patients with rheumatoid arthritis.

Takehisa Ogura, Chihiro Imaizumi, Ayako Hirata

Pageof 7

Frequent Collaborators

11 joint publications

Yoshiya Tanaka

7 joint publications

Yuko Kaneko

6 joint publications

Tsutomu Takeuchi

5 joint publications

Kei Ikeda